Hotel Royal Limited (SGX:H12)

Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions SGD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 13, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	235	214	226	247	312	274
Market Cap Growth	11.18%	-5.35%	-8.33%	-21.03%	13.97%	-9.63%
Enterprise Value	367	343	347	407	472	364
Last Close Price	1.94	1.74	1.82	1.96	2.92	2.54
PE Ratio	38.98	32.02	45.11	-	-	-
PS Ratio	3.37	3.21	3.88	5.89	11.89	8.96
PB Ratio	0.33	0.30	0.33	0.39	0.54	0.44
P/TBV Ratio	0.33	0.30	0.33	0.39	0.54	0.44
P/FCF Ratio	91.49	-	-	-	-	-
P/OCF Ratio	17.11	18.86	27.46	35.41	-	-
EV/Sales Ratio	5.28	5.14	5.95	9.71	17.98	11.89
EV/EBITDA Ratio	16.97	16.09	19.28	40.52	-	82.27
EV/EBIT Ratio	25.70	24.10	28.83	133.97	-	-
EV/FCF Ratio	143.19	-	-	-	-	-
Debt / Equity Ratio	0.23	0.23	0.23	0.28	0.34	0.21
Debt / EBITDA Ratio	7.35	7.64	8.81	17.36	-	28.87
Debt / FCF Ratio	62.04	-	-	-	-	-
Asset Turnover	0.08	0.08	0.07	0.05	0.03	0.04
Inventory Turnover	36.14	33.33	33.42	30.29	21.62	20.28
Quick Ratio	2.06	1.83	1.65	1.90	1.19	1.76
Current Ratio	2.11	2.05	1.78	1.96	1.26	2.37
Return on Equity (ROE)	0.87%	0.96%	0.76%	-0.57%	-0.62%	-3.18%
Return on Assets (ROA)	1.02%	1.01%	0.89%	0.23%	-0.87%	-0.26%
Return on Capital (ROIC)	1.05%	1.04%	0.92%	0.24%	-0.90%	-0.27%
Return on Capital Employed (ROCE)	1.60%	1.60%	1.40%	0.40%	-	-
Earnings Yield	2.56%	3.12%	2.22%	-1.39%	-1.19%	-7.60%
FCF Yield	1.09%	-1.08%	-4.32%	-0.77%	-1.75%	-2.36%
Dividend Yield	1.39%	1.55%	1.38%	1.28%	0.85%	0.98%
Payout Ratio	54.26%	45.23%	60.31%	-	-	-
Buyback Yield / Dilution	0.05%	-	-17.73%	-1.67%	-0.25%	-
Total Shareholder Return	1.44%	1.55%	-16.36%	-0.40%	0.61%	0.98%

Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.